MedTrace Logo

Body Composition Changes With Albuterol and Caffeine Versus Placebo in Adolescents

NCT02740660 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 12

Last updated 2019-10-08

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to determine whether taking a combination of caffeine and albuterol three times per day will increase muscle and decrease fat in your child's body and to determine how these medications make your child feel. Albuterol is approved by the FDA for the treatment of asthma. It is not approved to increase muscle and decrease body fat in children.

Conditions

  • Pediatric Obesity

Interventions

DRUG

Caffeine 100mg / Albuterol 4mg

DRUG

Placebo

BEHAVIORAL

Family weight management counseling

Sponsors & Collaborators

  • Leverage Innovation for Technology Transfer Fund (LSU LIFT2)

    collaborator UNKNOWN

  • Pennington Biomedical Research Center

    lead OTHER

Principal Investigators

  • Daniel Hsia, PhD · Pennington Biomedical Research Center

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
12 Years
Max Age
17 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-04-30
Primary Completion
2017-10-24
Completion
2017-10-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02740660 on ClinicalTrials.gov